IGF-1 monitoring : Dosage adjustments depend on IGF-1 blood test results and clinical response
After Reconstitution: Store the solution in a refrigerator at 28C (35.646.4F) at all times
Is Thymosin Alpha-1 FDA-approved for long COVID
Peptides included: GHK-Cu BPC-157 AOD-960 CJC-1295 / Ipamorelin DSIP Ipamorelin MOTS-C PT-141 Sermorelin Thymosin Alpha-1 Thymosin Beta-4 Gut & Inflammation Peptides Designed to repair the gut lining, reduce inflammation, restore digestive balance and support systemic healing, essential for patients experiencing bloating, IBS, sensitivities or gut-related fatigue
Based on both published research and our clinical observations in Dubai, here is a realistic BPC-157 timeline: Week 12: Early Signals Reduced acute pain and swelling at injury sites Improved gut comfort less bloating, cramping, or urgency Improved sleep quality (indirect effect via reduced pain and inflammation) Mild energy improvement Week 24: Visible Progress Noticeable improvement in range of motion for tendon/joint issues Meaningful reduction in chronic pain scores Gut healing measurable patients with ulcers or leaky gut symptoms report significant improvement Muscle recovery between training sessions accelerates Week 48: Structural Repair Tendon and ligament strength improvements become functional Scar tissue remodeling begins (particularly relevant when combined with GHK-Cu) Nerve pain reduction in neuropathic cases Full gut repair in most moderate-to-severe cases Week 812: Long-Term Consolidation Ongoing structural repair with continued dosing under monitoring Sustained pain reduction that persists after cycle completion Some patients report continued improvement for 46 weeks post-cycle as tissue remodeling continues Important: Individual results vary based on injury severity, age, lifestyle, and protocol specifics
FDA Regulation & Sourcing The peptide landscape shifted in October 2023 when the FDA placed several popular peptides on a Category 2 list, meaning they could no longer be compounded by pharmacies
